Eriksson JW, Fanni G, Lundqvist MH, Jansson S, et al. SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications. Diabetes Obes Metab 2025 Nov 28. doi: 10.1111/dom.70320.
PMID: 41311237